ALHC has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ALHC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Alignment Healthcare's Enterprise Value is $855 Mil. Alignment Healthcare's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-127 Mil. Therefore, Alignment Healthcare's EV-to-EBIT for today is -6.73.
The historical rank and industry rank for Alignment Healthcare's EV-to-EBIT or its related term are showing as below:
During the past 5 years, the highest EV-to-EBIT of Alignment Healthcare was -4.32. The lowest was -531.92. And the median was -10.46.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Alignment Healthcare's Enterprise Value for the quarter that ended in Dec. 2023 was $1,480 Mil. Alignment Healthcare's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-127 Mil. Alignment Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -8.58%.
The historical data trend for Alignment Healthcare's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alignment Healthcare Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
EV-to-EBIT | - | - | -13.06 | -14.95 | -11.66 |
Alignment Healthcare Quarterly Data | |||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | |
EV-to-EBIT | Get a 7-Day Free Trial | -14.95 | -6.90 | -5.16 | -7.05 | -11.66 |
For the Healthcare Plans subindustry, Alignment Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Plans industry and Healthcare sector, Alignment Healthcare's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Alignment Healthcare's EV-to-EBIT falls into.
Alignment Healthcare's EV-to-EBIT for today is calculated as:
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 854.827 | / | -126.964 | |
= | -6.73 |
Alignment Healthcare's current Enterprise Value is $855 Mil.
Alignment Healthcare's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-127 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alignment Healthcare (NAS:ALHC) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.
Alignment Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:
Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) | = | EBIT | / | Enterprise Value (Q: Dec. 2023 ) |
= | -126.964 | / | 1479.97072 | |
= | -8.58 % |
Alignment Healthcare's Enterprise Value for the quarter that ended in Dec. 2023 was $1,480 Mil.
Alignment Healthcare's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-127 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Alignment Healthcare's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Jeffrey H Margolis | director | 567 SAN NICHOLAS DRIVE, SUITE 360, NEWPORT BEACH CA 92660 |
Joseph S Konowiecki | director | 5995 PLAZA DR, CYPRESS CA 90630 |
Hyong Kim | officer: Chief Medical Officer | C/O ALIGNMENT HEALTHCARE, INC., 1100 W TOWN AND COUNTRY ROAD, SUITE 1600, ORANGE CA 92868 |
Christopher J Joyce | officer: Chief Legal and Admin. Officer | C/O ALLIANCE ENTERTAINMENT CORP, 110 EAST 59TH STREET 18TH FLOOR, NEW YORK NY 10022 |
Melinda Michele Kimbro | officer: Chief People Officer | 6155 EL CAMINO REAL, CARLSBAD CA 92009 |
Robert L. Scavo | officer: Chief Information Officer | C/O ALIGNMENT HEALTHCARE, INC., 1100 W. TOWN AND COUNTRY ROAD, SUITE 160, ORANGE CA 92868 |
Hakan Kardes | officer: Chief Technology Officer | C/O ALIGNMENT HEALTHCARE, INC., 1100 W. TOWN AND COUNTRY ROAD, SUITE 160, ORANGE CA 92868 |
Robert Thomas Freeman | officer: Chief Financial Officer | C/O ALIGNMENT HEALTHCARE, INC., 1100 W. TOWN & COUNTRY ROAD, SUITE 1600, ORANGE CA 92868 |
Dinesh M. Kumar | officer: Chief Health Officer | C/O ALIGNMENT HEALTHCARE, INC., 1100 W. TOWN & COUNTRY ROAD, SUITE 1600, ORANGE CA 92868 |
Dawn Christine Maroney | officer: President, Markets | C/O ALIGNMENT HEALTHCARE, INC., 1100 W. TOWN & COUNTRY ROAD, SUITE 1600, ORANGE CA 92868 |
John E Kao | director, officer: Chief Executive Officer | |
Richard A. Cross | officer: SVP, General Counsel | C/O ALIGNMENT HEALTHCARE, INC., 1100 W. TOWN AND COUNTRY ROAD, STE. 1600, ORANGE CA 92868 |
Warburg Pincus Llc | director, 10 percent owner | 450 LEXINGTON AVENUE, NEW YORK NY 10017 |
General Atlantic (aln Hlth), L.p. | director, 10 percent owner | C/O GENERAL ATLANTIC SERVICE COMPANY, LP, 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055 |
General Atlantic, L.p. | director, 10 percent owner | 55 EAST 52ND STREET, 33RD FLOOR, NEW YORK NY 10055 |
From GuruFocus
By Marketwired • 09-07-2023
By Marketwired • 07-31-2023
By GuruFocus Research • 01-09-2024
By Marketwired • 07-06-2023
By Marketwired • 07-13-2023
By GuruFocus Research • 12-06-2023
By Marketwired • 10-02-2023
By GuruFocus Research • 09-15-2023
By Marketwired • 07-05-2023
By Marketwired • 07-17-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.